SEC Form 4 · accession 0001209191-16-148720
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paresh Soni
Officer — Chief Medical Officer
Period of report
Nov 3, 2016
Accepted (ET)
Nov 7, 2016 · 6:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $19.47 | Nov 3, 2016 | A | 81,831 | A | — | Nov 2, 2026 | Common Stock | 81,831 | 81,831 | D |
Explanation of responses
- F1This option vests and becomes exercisable as to 25% of the underlying shares on September 6, 2017 and the remainder in equal installments on the last day of the 12 consecutive calendar quarters beginning with December 31, 2017 and ending on September 30, 2020.